This website is for UK Healthcare Professionals only

Prescribing information and adverse event reporting information can be found at the bottom of this page.

Gastroenterology

 

RINVOQ®(upadacitinib)

UK-RNQG-220017. Date of preparation: July 2022

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. 
Adverse events should also be reported to AbbVie on GBPV@abbvie.com